{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:11:57Z","timestamp":1791573117871,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2022QB250"],"award-info":[{"award-number":["ZR2022QB250"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260555, 42407101"],"award-info":[{"award-number":["82260555, 42407101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Science and Technology Projects of Gansu Province","award":["22ZD6FA021-4"],"award-info":[{"award-number":["22ZD6FA021-4"]}]},{"name":"Joint Research Fund General Projects of Gansu Province","award":["23JRRA1508"],"award-info":[{"award-number":["23JRRA1508"]}]},{"name":"Gansu Provincial Top-notch Talent Program","award":["(2023)9"],"award-info":[{"award-number":["(2023)9"]}]},{"name":"Cuiying Science and Technology Innovation Project of the Second Hospital of Lanzhou University","award":["CY2024-CQ-01"],"award-info":[{"award-number":["CY2024-CQ-01"]}]},{"name":"Public Hospital High-quality Development of Scientific Research Project of Chinese Health Promotion Foundation","award":["GL-C032"],"award-info":[{"award-number":["GL-C032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04171-1","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:27:47Z","timestamp":1771849667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting redox metabolism and low-dose radiotherapy synergistically activate cGAS-STING pathway to improve NK cell therapy efficacy in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Bo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhui","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wence","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"4171_CR1","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1097\/CM9.0000000000003264","volume":"137","author":"Q Li","year":"2024","unstructured":"Li Q, Ding C, Cao M, Yang F, Yan X, He S, Cao M, Zhang S, Teng Y, Tan N, et al. Global epidemiology of liver cancer 2022: an emphasis on geographic disparities. Chin Med J (Engl). 2024;137:2334\u201342.","journal-title":"Chin Med J (Engl)"},{"key":"4171_CR2","doi-asserted-by":"publisher","first-page":"e877","DOI":"10.1016\/S2468-2667(21)00157-2","volume":"6","author":"H Zeng","year":"2021","unstructured":"Zeng H, Ran X, An L, Zheng R, Zhang S, Ji JS, Zhang Y, Chen W, Wei W, He J. Disparities in stage at diagnosis for five common cancers in china: a multicentre, hospital-based, observational study. Lancet Public Health. 2021;6:e877\u201387.","journal-title":"Lancet Public Health"},{"key":"4171_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, Qin W, Fan J, Wang C, Gao Q. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42:180\u201397.","journal-title":"Cancer Cell"},{"key":"4171_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12885-024-12334-2","volume":"24","author":"Y Qin","year":"2024","unstructured":"Qin Y, Tang C, Li J, Gong J. Liver cancer in china: the analysis of mortality and burden of disease trends from 2008 to 2021. BMC Cancer. 2024;24:594.","journal-title":"BMC Cancer"},{"key":"4171_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-023-01737-7","volume":"22","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Cheng L, Liu L, Li X. NK cells are never alone: crosstalk and communication in tumour microenvironments. Mol Cancer. 2023;22:34.","journal-title":"Mol Cancer"},{"key":"4171_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","volume":"626","author":"E Vivier","year":"2024","unstructured":"Vivier E, Rebuffet L, Narni-Mancinelli E, Cornen S, Igarashi RY, Fantin VR. Natural killer cell therapies. Nature. 2024;626:727\u201336.","journal-title":"Nature"},{"key":"4171_CR7","doi-asserted-by":"crossref","unstructured":"Kalathil SG, Thanavala Y. Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches. Cells 2021, 10.","DOI":"10.3390\/cells10061332"},{"key":"4171_CR8","doi-asserted-by":"publisher","first-page":"1454427","DOI":"10.3389\/fimmu.2024.1454427","volume":"15","author":"H Park","year":"2024","unstructured":"Park H, Kim G, Kim N, Ha S, Yim H. Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis. Front Immunol. 2024;15:1454427.","journal-title":"Front Immunol"},{"key":"4171_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.14701\/ahbps.2021.25.2.206","volume":"25","author":"JM Kim","year":"2021","unstructured":"Kim JM, Cho SY, Rhu J, Jung M, Her JH, Lim O, Choi GS, Shin EC, Hwang YK, Joh JW. Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study. Ann Hepatobiliary Pancreat Surg. 2021;25:206\u201314.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"4171_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12951-025-03424-9","volume":"23","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Gong Y, Li X, Zeng F, Liu B, Chen W, Zhang F, Chen H, Zhu W, Li H, et al. A spreadable self-gelling hemostatic powder sensitizes CAR-NK cell therapy to prevent hepatocellular carcinoma recurrence postresection. J Nanobiotechnol. 2025;23:353.","journal-title":"J Nanobiotechnol"},{"key":"4171_CR11","doi-asserted-by":"publisher","first-page":"113037","DOI":"10.1016\/j.intimp.2024.113037","volume":"141","author":"CY Fan","year":"2024","unstructured":"Fan CY, Zheng JS, Hong LL, Ling ZQ. Macrophage crosstalk and therapies: between tumor cells and immune cells. Int Immunopharmacol. 2024;141:113037.","journal-title":"Int Immunopharmacol"},{"key":"4171_CR12","doi-asserted-by":"publisher","first-page":"113783","DOI":"10.1016\/j.jconrel.2025.113783","volume":"383","author":"X Yin","year":"2025","unstructured":"Yin X, Zhao X, Shen Y, Xie W, He C, Guo J, Li Z, Xuan F, Zeng S, Zeng X, Fang C. Nanoparticle-mediated dual targeting of stromal and immune components to overcome fibrotic and immunosuppressive barriers in hepatocellular carcinoma. J Control Release. 2025;383:113783.","journal-title":"J Control Release"},{"key":"4171_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","volume":"18","author":"M Shen","year":"2025","unstructured":"Shen M, Jiang X, Peng Q, Oyang L, Ren Z, Wang J, Peng M, Zhou Y, Deng X, Liao Q. The cGAS\u2013STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications. J Hematol Oncol. 2025;18:40.","journal-title":"J Hematol Oncol"},{"key":"4171_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7150\/ijbs.65019","volume":"18","author":"X Yan","year":"2022","unstructured":"Yan X, Yao C, Fang C, Han M, Gong C, Hu D, Shen W, Wang L, Li S, Zhu S. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Int J Biol Sci. 2022;18:585\u201398.","journal-title":"Int J Biol Sci"},{"key":"4171_CR15","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1021\/acscentsci.1c00440","volume":"7","author":"AF Cordova","year":"2021","unstructured":"Cordova AF, Ritchie C, B\u00f6hnert V, Li L. Human SLC46A2 is the dominant cGAMP importer in extracellular cGAMP-Sensing macrophages and monocytes. ACS Cent Sci. 2021;7:1073\u201388.","journal-title":"ACS Cent Sci"},{"key":"4171_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.molcel.2020.10.021","volume":"80","author":"LJ Lahey","year":"2020","unstructured":"Lahey LJ, Mardjuki RE, Wen X, Hess GT, Ritchie C, Carozza JA, B\u00f6hnert V, Maduke M, Bassik MC, Li L. LRRC8A:C\/E heteromeric channels are ubiquitous transporters of cGAMP. Mol Cell. 2020;80:578\u2013e591575.","journal-title":"Mol Cell"},{"key":"4171_CR17","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1016\/j.ymthe.2025.01.043","volume":"33","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Chan WL, Fung SY, Pang L, Ding T, Teo JMN, Zhou Y, Wu CMA, Siu KL, Bi J, et al. Centrosome protein TAX1BP2 mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in hepatocellular carcinoma. Mol Ther. 2025;33:2913\u201330.","journal-title":"Mol Ther"},{"key":"4171_CR18","doi-asserted-by":"publisher","first-page":"123068","DOI":"10.1016\/j.biomaterials.2024.123068","volume":"317","author":"Y Gong","year":"2025","unstructured":"Gong Y, Cheng Y, Zeng F, Liu X, Yang Y, Zhang F, Wen C, Yang F, Li H, He Y, et al. A self-gelling hemostatic powder boosting radiotherapy-elicited NK cell immunity to combat postoperative hepatocellular carcinoma relapse. Biomaterials. 2025;317:123068.","journal-title":"Biomaterials"},{"key":"4171_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12951-025-03229-w","volume":"23","author":"X Hu","year":"2025","unstructured":"Hu X, Zhu H, Shen Y, Rao L, Li J, He X, Xu X. Metal-organic framework nanoparticles activate cGAS-STING pathway to improve radiotherapy sensitivity. J Nanobiotechnol. 2025;23:131.","journal-title":"J Nanobiotechnol"},{"key":"4171_CR20","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/ijc.34801","volume":"154","author":"L Zhou","year":"2024","unstructured":"Zhou L, Liu Y, Wu Y, Yang X, Spring Kong FM, Lu Y, Xue J. Low-dose radiation therapy mobilizes antitumor immunity: new findings and future perspectives. Int J Cancer. 2024;154:1143\u201357.","journal-title":"Int J Cancer"},{"key":"4171_CR21","doi-asserted-by":"publisher","first-page":"e359","DOI":"10.1038\/emm.2017.85","volume":"49","author":"J Kim","year":"2017","unstructured":"Kim J, Jung Y. Radiation-induced liver disease: current Understanding and future perspectives. Exp Mol Med. 2017;49:e359.","journal-title":"Exp Mol Med"},{"key":"4171_CR22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1186\/s12967-024-05724-4","volume":"22","author":"X Lin","year":"2024","unstructured":"Lin X, Liu Z, Dong X, Wang K, Sun Y, Zhang H, Wang F, Chen Y, Ling J, Guo Y, et al. Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma. J Transl Med. 2024;22:929.","journal-title":"J Transl Med"},{"key":"4171_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ijrobp.2021.05.014","volume":"111","author":"J Sia","year":"2021","unstructured":"Sia J, Hagekyriakou J, Chindris I, Albarakati H, Leong T, Schlenker R, Keam SP, Williams SG, Neeson PJ, Johnstone RW, Haynes NM. Regulatory T cells shape the differential impact of radiation Dose-Fractionation schedules on host innate and adaptive antitumor immune defenses. Int J Radiat Oncol Biol Phys. 2021;111:502\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4171_CR24","doi-asserted-by":"publisher","first-page":"e202417027","DOI":"10.1002\/anie.202417027","volume":"64","author":"C Wang","year":"2025","unstructured":"Wang C, Li J, Jiang X, Ma X, Zhen W, Tillman L, Weichselbaum RR, Lin W. Bifunctional Metal-Organic framework synergistically enhances radiotherapy and activates STING for potent cancer Radio-Immunotherapy. Angew Chem Int Ed Engl. 2025;64:e202417027.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4171_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.canlet.2019.02.034","volume":"450","author":"H Wang","year":"2019","unstructured":"Wang H, Jiang H, Corbet C, de Mey S, Law K, Gevaert T, Feron O, De Ridder M. Piperlongumine increases sensitivity of colorectal cancer cells to radiation: involvement of ROS production via dual Inhibition of glutathione and thioredoxin systems. Cancer Lett. 2019;450:42\u201352.","journal-title":"Cancer Lett"},{"key":"4171_CR26","doi-asserted-by":"crossref","unstructured":"Brandl N, Seitz R, Sendtner N, M\u00fcller M, G\u00fclow K. Living on the edge: ROS homeostasis in cancer cells and its potential as a therapeutic target. Antioxid (Basel). 2025;14(8):1002.","DOI":"10.3390\/antiox14081002"},{"key":"4171_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/med.21872","volume":"42","author":"T Gamberi","year":"2022","unstructured":"Gamberi T, Chiappetta G, Fiaschi T, Modesti A, Sorbi F, Magherini F. Upgrade of an old drug: auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness. Med Res Rev. 2022;42:1111\u201346.","journal-title":"Med Res Rev"},{"key":"4171_CR28","doi-asserted-by":"publisher","first-page":"e2306031","DOI":"10.1002\/advs.202306031","volume":"11","author":"C Du","year":"2024","unstructured":"Du C, Guo X, Qiu X, Jiang W, Wang X, An H, Wang J, Luo Y, Du Q, Wang R, et al. Self-Reinforced bimetallic Mito-Jammer for Ca(2+) Overload-Mediated cascade mitochondrial damage for cancer Cuproptosis sensitization. Adv Sci (Weinh). 2024;11:e2306031.","journal-title":"Adv Sci (Weinh)"},{"key":"4171_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jconrel.2023.07.056","volume":"361","author":"M Kai","year":"2023","unstructured":"Kai M, Wang S, Gao W, Zhang L. Designs of metal-organic framework nanoparticles for protein delivery. J Control Release. 2023;361:178\u201390.","journal-title":"J Control Release"},{"key":"4171_CR30","doi-asserted-by":"publisher","first-page":"27042","DOI":"10.1021\/acsnano.4c10012","volume":"18","author":"B Li","year":"2024","unstructured":"Li B, Wu C, Li Z, Yao Z, Tian J, Shan Y, Chen S, Song W, Pan W, Ping Y, Liu B. Tumor Microenvironment-Activated in situ synthesis of peroxynitrite for enhanced chemodynamic therapy. ACS Nano. 2024;18:27042\u201354.","journal-title":"ACS Nano"},{"key":"4171_CR31","doi-asserted-by":"publisher","first-page":"e2301346","DOI":"10.1002\/adhm.202301346","volume":"12","author":"F Zhao","year":"2023","unstructured":"Zhao F, Yu H, Liang L, Wang C, Shi D, Zhang X, Ying Y, Cai W, Li W, Li J, et al. Redox homeostasis disruptors based on Metal-Phenolic network nanoparticles for Chemo\/Chemodynamic synergistic tumor therapy through activating apoptosis and Cuproptosis. Adv Healthc Mater. 2023;12:e2301346.","journal-title":"Adv Healthc Mater"},{"key":"4171_CR32","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1038\/s41467-019-09015-1","volume":"10","author":"R Piranlioglu","year":"2019","unstructured":"Piranlioglu R, Lee E, Ouzounova M, Bollag RJ, Vinyard AH, Arbab AS, Marasco D, Guzel M, Cowell JK, Thangaraju M, et al. Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model. Nat Commun. 2019;10:1430.","journal-title":"Nat Commun"},{"key":"4171_CR33","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.1038\/s41467-024-50474-y","volume":"15","author":"QN Ye","year":"2024","unstructured":"Ye QN, Zhu L, Liang J, Zhao DK, Tian TY, Fan YN, Ye SY, Liu H, Huang XY, Cao ZT, et al. Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity. Nat Commun. 2024;15:6211.","journal-title":"Nat Commun"},{"key":"4171_CR34","doi-asserted-by":"publisher","first-page":"124799","DOI":"10.1016\/j.ijpharm.2024.124799","volume":"666","author":"K \u00d6zt\u00fcrk","year":"2024","unstructured":"\u00d6zt\u00fcrk K, Kaplan M, \u00c7al\u0131\u015f S. Effects of nanoparticle size, shape, and zeta potential on drug delivery. Int J Pharm. 2024;666:124799.","journal-title":"Int J Pharm"},{"key":"4171_CR35","doi-asserted-by":"publisher","first-page":"e2310230","DOI":"10.1002\/advs.202310230","volume":"11","author":"X Yang","year":"2024","unstructured":"Yang X, Chen M, Weng C, Zhuge D, Jin F, Xiao Y, Tian D, Yin Q, Li L, Zhang X, et al. Red blood cell Membrane-Coated nanoparticles enable incompatible blood transfusions. Adv Sci (Weinh). 2024;11:e2310230.","journal-title":"Adv Sci (Weinh)"},{"key":"4171_CR36","doi-asserted-by":"publisher","first-page":"8675","DOI":"10.2147\/IJN.S523766","volume":"20","author":"M Tu","year":"2025","unstructured":"Tu M, Deng X, Lai B, Liu J, Tao Y, Xu S, Li X, Niu X, Li Z, Huang J, et al. Copper-Based Metal-Organic framework nanoplatform for MiRNA delivery: synergistic antitumor therapy. Int J Nanomed. 2025;20:8675\u201392.","journal-title":"Int J Nanomed"},{"key":"4171_CR37","doi-asserted-by":"publisher","first-page":"1558814","DOI":"10.3389\/fimmu.2025.1558814","volume":"16","author":"J Luo","year":"2025","unstructured":"Luo J, Zhi Q, Li D, Xu Y, Zhu H, Zhao L, Ren G, Wang J, Liu N. Low dose radiotherapy combined with immune checkpoint inhibitors induces ferroptosis in lung cancer via the Nrf2\/HO-1\/GPX4 axis. Front Immunol. 2025;16:1558814.","journal-title":"Front Immunol"},{"key":"4171_CR38","doi-asserted-by":"crossref","unstructured":"Stafford WC, Peng X, Olofsson MH, Zhang X, Luci DK, Lu L, Cheng Q, Tr\u00e9saugues L, Dexheimer TS, Coussens NP et al. Irreversible Inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci Transl Med. 2018;10(428):eaaf7444.","DOI":"10.1126\/scitranslmed.aaf7444"},{"key":"4171_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167\u201397.","journal-title":"Cancer Cell"},{"key":"4171_CR40","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1186\/s12951-025-03810-3","volume":"23","author":"C Li","year":"2025","unstructured":"Li C, Zhang Z, Luo C, Lan W, Liu C, Liu W, Xiang H, Yang J, Tang Y, Wang X. A mitochondria-targeted nanomedicine for myocardial ischemia\/reperfusion injury with synergistic antioxidant and anti-inflammatory properties. J Nanobiotechnol. 2025;23:705.","journal-title":"J Nanobiotechnol"},{"key":"4171_CR41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-025-02366-y","volume":"24","author":"Q Zeng","year":"2025","unstructured":"Zeng Q, Liu M, Wang Z, Zhou R, Ai K. Enhancing radiotherapy-induced anti-tumor immunity via nanoparticle-mediated STING agonist synergy. Mol Cancer. 2025;24:176.","journal-title":"Mol Cancer"},{"key":"4171_CR42","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41401-023-01210-7","volume":"45","author":"XY Ma","year":"2024","unstructured":"Ma XY, Chen MM, Meng LH. Second messenger 2\u20193\u2019-cyclic GMP-AMP (2\u20193\u2019-cGAMP): the cell autonomous and non-autonomous roles in cancer progression. Acta Pharmacol Sin. 2024;45:890\u20139.","journal-title":"Acta Pharmacol Sin"},{"key":"4171_CR43","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1038\/s41467-024-48214-3","volume":"15","author":"FM Walker","year":"2024","unstructured":"Walker FM, Sobral LM, Danis E, Sanford B, Donthula S, Balakrishnan I, Wang D, Pierce A, Karam SD, Kargar S, et al. Rapid P-TEFb-dependent transcriptional reorganization underpins the glioma adaptive response to radiotherapy. Nat Commun. 2024;15:4616.","journal-title":"Nat Commun"},{"key":"4171_CR44","doi-asserted-by":"publisher","first-page":"e2302220","DOI":"10.1002\/adma.202302220","volume":"35","author":"N Liu","year":"2023","unstructured":"Liu N, Zhu J, Zhu W, Chen L, Li M, Shen J, Chen M, Wu Y, Pan F, Deng Z, et al. X-ray-Induced release of nitric oxide from Hafnium-Based nanoradiosensitizers for enhanced Radio-Immunotherapy. Adv Mater. 2023;35:e2302220.","journal-title":"Adv Mater"},{"key":"4171_CR45","doi-asserted-by":"publisher","first-page":"e2413010","DOI":"10.1002\/advs.202413010","volume":"12","author":"W Liu","year":"2025","unstructured":"Liu W, Wang J, Yang H, Li C, Lan W, Chen T, Tang Y. The metabolite Indole-3-Acetic acid of bacteroides ovatus improves atherosclerosis by restoring the polarisation balance of M1\/M2 macrophages and inhibiting inflammation. Adv Sci (Weinh). 2025;12:e2413010.","journal-title":"Adv Sci (Weinh)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04171-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04171-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04171-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:02:28Z","timestamp":1774886548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04171-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4171"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04171-1","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the ARRIVE guidelines and the U.K. Animals (Scientific Procedures) Act, 1986. Experimental procedures were approved by the Ethics Committee for Animal Experimentation at our institution (Approval No. 2024\u2009\u2212\u2009639).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"295"}}